In yesterday’s Wall Street session, Geron Corporation (NASDAQ:GERN) shares traded at $2.96, down -6.33% from the previous session.
As of this writing, 6 analysts cover Geron Corporation (NASDAQ:GERN). The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $6.00 and a low of $4.00, we find $5.00. Given the previous closing price of $3.16, this indicates a potential upside of 58.23 percent. GERN stock price is now -7.93% away from the 50-day moving average and 8.90% away from the 200-day moving average. The market capitalization of the company currently stands at $1.61B.
There are 1 analysts who have given it a hold rating, whereas 4 have given it a buy rating. Brokers who have rated the stock have averaged $4.83 as their price target over the next twelve months.
With the price target of $3, Goldman recently initiated with Neutral rating for Geron Corporation (NASDAQ: GERN).
In other news, LAWLIS V BRYAN, Director sold 35,000 shares of the company’s stock on May 11. The stock was sold for $105,000 at an average price of $3.00. Upon completion of the transaction, the Director now directly owns 0 shares in the company, valued at $0.0. An SEC document containing details of the transaction can be found on the SEC’s website. On May 01, Director Molineaux Susan sold 35,000 shares of the business’s stock. A total of $86,800 was realized by selling the stock at an average price of $2.48. Insiders disposed of 2,194,719 shares of company stock worth roughly $6.5 million over the past 1 year. A total of 0.10% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in GERN stock. A new stake in Geron Corporation shares was purchased by FAIRMOUNT FUNDS MANAGEMENT LLC during the first quarter worth $21,029,000. ARTAL GROUP S.A. invested $16,475,000 in shares of GERN during the first quarter. In the first quarter, BAKER BROS. ADVISORS LP acquired a new stake in Geron Corporation valued at approximately $9,061,000. POINT72 ASSET MANAGEMENT, L.P. acquired a new stake in GERN for approximately $8,860,000. OCTAGON CAPITAL ADVISORS LP purchased a new stake in GERN valued at around $6,743,000 in the second quarter. In total, there are 249 active investors with 50.50% ownership of the company’s stock.
During the past 12 months, Geron Corporation has had a low of $1.95 and a high of $3.84. As of last week, the company has a debt-to-equity ratio of 0.17, a current ratio of 5.20, and a quick ratio of 5.20. The fifty day moving average price for GERN is $3.2126 and a two-hundred day moving average price translates $2.7215 for the stock.
The latest earnings results from Geron Corporation (NASDAQ: GERN) was released for Jun, 2023. According to the Biotechnology Company, earnings per share came in at -$0.07, beating analysts’ expectations of -$0.1 by 0.03. This compares to -$0.07 EPS in the same period last year. The company reported revenue of $29000.0 for the quarter, compared to $73000.0 a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -60.27 percent. For the current quarter, analysts expect GERN to generate $70k in revenue.
